Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Ackman Shoots Down Idea of Valeant (VRX) Unloading Bausch & Lomb
April 8, 2016 6:29 AM EDTPershing Square's Bill Ackman, speaking on CNBC late Thursday, said that Valeant Pharma (NYSE: VRX) isn't going to... More
